FDA's Juul inquiry found consumers had 2,600 health complaints

Juul Labs received approximately 2,600 complaints about adverse health effects related to its e-cigarette during its first 3 years in operation, according to an internal FDA report, with customers citing issues such as burning sensations in the lungs, blistered lips, and vomiting.

Juul Labs received approximately 2,600 complaints about adverse health effects related to its e-cigarette during its first 3 years in operation, according to an internal FDA report, with customers citing issues such as burning sensations in the lungs, blistered lips, and vomiting. The rate of complaints received per Juul pods sold "is very low," said Austin Finan, a Juul spokesman. "We take product safety very seriously and implement stringent quality control measures to ensure the safety of all our products." The customer complaints were contained in a Juul Labs database that FDA reviewed as part of a 2018 inspection of the firm. The agency's inquiry remains ongoing. The company's internal database logged nearly 1.3 million general complaints from both adults and youth between June 1, 2015, when Juul first launched its product, and Sept. 26, 2018. Only 317 of them were categorized as "health experiences" or "health events," but Juul later uncovered an additional 2,300 health related complaints that were not captured by the database. The additional cases surfaced only after the company became aware in July 2018 that some consumers were submitting complaints through an online channel that asked users to "elaborate on their Juul experience."